引用次数
引用: 63,129
H-指数: 101
I10-指数 : 366
出版物: 915
P1.14-26 ALK Fusion Variant Detection by Targeted RNA-Seq in TKIs Treated ALK-Positive Lung Adenocarcinoma
F. Tabbò , E. Gobbini , L. Muscarella , A. Rigutto
Journal of Thoracic Oncology 14 ( 10)
2019
O-182 Early lung cancer detection decreases surgical mortality
U. Pastorino , P. Borasio , M. Bellomi , C. Fava
Lung Cancer 49
2005
PD-031 Molecular analysis of the epidermal growth factor receptorpathway in 24 consecutive early stage non small cell lung cancers
M. Volante , S. Saviozzi , I. Rapa , P. Lausi
Lung Cancer 49
2005
PD-025 Prognostic role of Protease-Activated Receptor 1 (PAR-1) and 4(PAR-4) in Stage IB non-small cell lung cancer (NSCLC)
G. Selvaggi , P. Lausi , P. Ghio , S. Novello
Lung Cancer 49
2005
15IN SYSTEMIC THERAPY. NON-SMALL CELL LUNG CANCER STAGE I AND II: TREATMENT STANDARDS AND NEW DEVELOPMENT
G. Scagliotti , S. Novello
Lung Cancer 64
2009
PD-083 Pemetrexed (P) plus carboplatin (Cb) as 1st treatment for patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC): Results of both a multi-center European and an MD Anderson Cancer Center (MDACC) phase II trials
R. Zinner , C. Kortsik , G. Dark , A. Price
Lung Cancer 49
1
2005
P-111 Identification of optimal housekeeping genes for gene expression profiling in non-small cell lung cancer
S. Saviozzi , M. Volante , M. Lo Iacono , M. Papotti
Lung Cancer 49
2005
P-268 Three-year findings of an early lung cancer detection feasibilitystudy with low-dose spiral computed tomography in heavy smokers
S. Novelle , G. Selvaggi , E. Perotto , P. Lausi
Lung Cancer 49
2005
P-267 Extrapulmonary findings in a low-dose spiral CT scan early detection study for lung cancer in a high risk population
S. Novelle , C. Fava , P. Lausi , L. Cardinale
Lung Cancer 49
2005
P-463 Preliminary results of a multicenter randomized phase II trial oftwo different combinations of docetaxel (D) and gemcitabine (G) and of cisplatin/gemcitabine (CG) followed by docetaxel as first line therapy for locally advanced or metastatic non small cell lung cancer (NSCLC)
I. Bernardini , M. Rinaldi , L. Crinò , M. Nardi
Lung Cancer 49
2005
O.04 Results from the IASLC Global Survey on Molecular Testing in Lung Cancer
M.V. Garcia , M. Smeltzer , M. Wynes , S. Lantuejoul
Journal of Thoracic Oncology 14 ( 11)
2019
OA01.09 Comparing Regional Results from the IASLC Global Survey on Molecular Testing in Lung Cancer
M. Smeltzer , M. Wynes , S. Lantuejoul , R.A. Soo
Journal of Thoracic Oncology 14 ( 11)
2019
YI01.02 Why to Become a Member of the IASLC
G. Scagliotti
Journal of Thoracic Oncology 14 ( 10)
2019
MA21.03 The International Association for the Study of Lung Cancer (IASLC) Global Survey on Molecular Testing in Lung Cancer
M. Smeltzer , M. Wynes , M. Taylor , K. Richeimer
Journal of Thoracic Oncology 14 ( 10)
2
2019
Phase 2 study of ceritinib in ALKi-naïve patients (pts) with ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC): Whole body responses in the overall pt group and in pts with baseline brain metastases (BM)
E Felip , S Orlov , K Park , C-J Yu
Annals of Oncology 27
21
2016
Symptomatic skeletal events (SSEs) versus skeletal-related events (SREs) in patients with advanced cancer and bone metastases treated with denosumab or zoledronic acid
R. von Moos , L.A.M. Costa , G. Scagliotti , H. Sleeboom
Annals of Oncology 27
2
2016
Ceritinib vs chemotherapy (CT) in patients (pts) with advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK+) non-small cell lung cancer (NSCLC) previously treated with CT and crizotinib (CRZ): Results from the confirmatory phase 3 ASCEND-5 study
G. Scagliotti , T.M. Kim , L. Crinò , G. Liu
Annals of Oncology 27
24
2016
Pharmacological bioquivalence of branded and generic oxaliplatin: from preclinical assessment to clinical incidence of hypersensitivity reactions in patients with colorectal cancer
C. Sonetto , C. Baratelli , M.P. Brizzi , M. Di Maio
Annals of Oncology 27
2016
9 Factors affecting response rate (RR) and survival (OS) in advanced non-small-cell lung cancer (NSCLC): Retrospective analysis on 1128 patients (pts)
L. Boni , M.C. Pennucci , A. Ardizzoni , L. Crinò
Lung Cancer 18 5
1
1997
Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872.
A. S. Th. Planting , A. Ardizzoni , J. Estap� , G. Giaccone
Cancer Chemotherapy and Pharmacology 28 ( 2) 145 -146
5
1991